Proteomic fingerprinting of protein corona formed on PEGylated multi-walled carbon nanotubes.
Drug-delivery
Human Plasma
Mass Spectrometry
PEGylated Carbon Nanotube
Protein Corona
Proteomics
Journal
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
ISSN: 1873-376X
Titre abrégé: J Chromatogr B Analyt Technol Biomed Life Sci
Pays: Netherlands
ID NLM: 101139554
Informations de publication
Date de publication:
15 Jan 2021
15 Jan 2021
Historique:
received:
15
07
2020
revised:
10
12
2020
accepted:
14
12
2020
pubmed:
8
1
2021
medline:
22
5
2021
entrez:
7
1
2021
Statut:
ppublish
Résumé
In Nanomedicine, carbon-based nanomaterials, like Carbon Nanotubes (CNT), are considered potential candidates as drug delivery systems. In vivo adsorption of physiological proteins onto carbon nanotubes, through noncovalent interactions, forms a protein corona or bio corona, able to influence biological properties and biocompatibility of CNT. This study aimed to explore the composition of protein corona formed onto PEGylated Multi-Walled Carbon Nanotubes (MWCNT-PEG5k), after their incubation in human plasma. Plasma proteins were sequentially eluted in different conditions by using both native and denaturant buffers, useful to characterize soft and hard corona. Proteomic methods and mass spectrometry analysis have identified proteins in soft corona, involved in the regulation of immune response and in the CNT transport, and biomolecules in hard corona with a role in the maintenance of host homeostasis. These promising results have demonstrated the potential of PEGylated Multi-Walled Carbon Nanotubes as future candidates for drug delivery.
Identifiants
pubmed: 33412504
pii: S1570-0232(20)31380-5
doi: 10.1016/j.jchromb.2020.122504
pii:
doi:
Substances chimiques
Blood Proteins
0
Nanotubes, Carbon
0
Protein Corona
0
Proteome
0
Polyethylene Glycols
3WJQ0SDW1A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122504Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.